Comparative analysis of pathology and behavioural phenotypes in mouse models of Huntington's disease
- PMID: 22004616
- DOI: 10.1016/j.brainresbull.2011.10.002
Comparative analysis of pathology and behavioural phenotypes in mouse models of Huntington's disease
Abstract
The longitudinal characterisation of Huntington's disease (HD) mouse lines is essential for the understanding of the differential developmental time course, nature and severity of phenotype progression over time. This overview outlines detailed behavioural, neuropathological and gene expression studies in four HD mouse lines: R6/1, YAC128, HdhQ92 and HdhQ150 and outlines their relevance to human HD. The review describes the similarities and differences between the models at the behavioural, anatomical and genetic levels of pathology and how these phenotypes interact in the development of disease in the lines. The HdhQ150 mouse demonstrates the most similarities to the functional deficits observed in human HD. The neuropathological profile with early cortical development of intense aggregate/inclusion pathology in the YAC128 mouse suggests that this line most resembles the development of inclusion pathology in the human disease. The gene expression analyses of the mouse lines find significant similarities between each of the lines and human HD, which converge as the mice age. In the YAC128 and HdhQ92 mouse lines some severe functional deficits are progressive whilst others are not, despite the concomitant ongoing development of neuropathological and gene expression changes. We suggest that the YAC128 and R6/1 lines may be more representative of the juvenile form of HD. The suitability of the different mouse models studied here for different types of pre-clinical therapeutic trials is discussed.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Similar striatal gene expression profiles in the striatum of the YAC128 and HdhQ150 mouse models of Huntington's disease are not reflected in mutant Huntingtin inclusion prevalence.BMC Genomics. 2015 Dec 21;16:1079. doi: 10.1186/s12864-015-2251-4. BMC Genomics. 2015. PMID: 26691352 Free PMC article.
-
C57BL/6 Background Attenuates mHTT Toxicity in the Striatum of YAC128 Mice.Int J Mol Sci. 2021 Nov 23;22(23):12664. doi: 10.3390/ijms222312664. Int J Mol Sci. 2021. PMID: 34884469 Free PMC article.
-
Longitudinal analysis of the behavioural phenotype in YAC128 (C57BL/6J) Huntington's disease transgenic mice.Brain Res Bull. 2012 Jun 1;88(2-3):113-20. doi: 10.1016/j.brainresbull.2010.05.005. Epub 2010 May 10. Brain Res Bull. 2012. PMID: 20460143
-
Mouse Models of Huntington's Disease.Curr Top Behav Neurosci. 2015;22:101-33. doi: 10.1007/7854_2013_256. Curr Top Behav Neurosci. 2015. PMID: 24357436 Review.
-
The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.NeuroRx. 2005 Jul;2(3):447-64. doi: 10.1602/neurorx.2.3.447. NeuroRx. 2005. PMID: 16389308 Free PMC article. Review.
Cited by
-
Longitudinal in vivo MRI in a Huntington's disease mouse model: Global atrophy in the absence of white matter microstructural damage.Sci Rep. 2016 Sep 1;6:32423. doi: 10.1038/srep32423. Sci Rep. 2016. PMID: 27581950 Free PMC article.
-
The central role of DNA damage and repair in CAG repeat diseases.Dis Model Mech. 2018 Jan 30;11(1):dmm031930. doi: 10.1242/dmm.031930. Dis Model Mech. 2018. PMID: 29419417 Free PMC article. Review.
-
Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway.Dis Model Mech. 2015 Sep;8(9):1047-57. doi: 10.1242/dmm.019406. Epub 2015 Jun 18. Dis Model Mech. 2015. PMID: 26092128 Free PMC article.
-
Reduced wheel running and blunted effects of voluntary exercise in LPA1-null mice: the importance of assessing the amount of running in transgenic mice studies.Neurosci Res. 2013 Nov;77(3):170-9. doi: 10.1016/j.neures.2013.09.004. Epub 2013 Sep 19. Neurosci Res. 2013. PMID: 24055600 Free PMC article.
-
Analysis of LINE1 Retrotransposons in Huntington's Disease.Front Cell Neurosci. 2022 Jan 14;15:743797. doi: 10.3389/fncel.2021.743797. eCollection 2021. Front Cell Neurosci. 2022. PMID: 35095420 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical